Publication date: 17 April 2018
Source:Immunity, Volume 48, Issue 4
Author(s): Shee-Mei Lok
There are no vaccines or therapies to treat Epstein-Barr virus (EBV). Snijder et al. (2018) isolated a potent human antibody against EBV that blocks infection of both B cells and epithelial cells. Structural analysis of the antibody complexed with a viral surface protein complex identified a site that may be useful in vaccine development.
Teaser
There are no vaccines or therapies to treat Epstein-Barr virus (EBV). Snijder et al. (2018) isolated a potent human antibody against EBV that blocks infection of both B cells and epithelial cells. Structural analysis of the antibody complexed with a viral surface protein complex identified a site that may be useful in vaccine development.https://ift.tt/2rlrnIL
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου